Posting of Annual Report and Notice of AGM

Summary by AI BETAClose X

TheraCryf plc has announced the posting of its Annual Report and Accounts for the year ended 31 March 2026, along with the Notice of its Annual General Meeting, which will be held on 22 October 2026. The company, focused on developing medicines for addiction and neuropsychiatric disorders, has made its reports available on its investor website. The lead orexin-1 receptor antagonist program is fully funded through pre-clinical trials to clinical readiness, with regulatory submissions for first-in-man studies targeted for 2026.

Disclaimer*

UK 100

Latest directors dealings